The result of real-time fluorescence quantitative polymerase chain reaction revealed that all the genes used to calculate the risk score were differentially expressed between BLCA and adjacent normal tissues, except PDGFRA. This evidence concerns the gene PDGFRA and bladder transitional cell carcinoma.